Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 46Active not recruiting 38Completed 19Not yet recruiting 12Terminated 4Enrolling by invitation 3Withdrawn 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Dermatologic 1

Conditions

Neoplasms 1Melanoma 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 116Carboplatin 48Nivolumab 46Paclitaxel 35Cyclophosphamide 35Cisplatin 34Gemcitabine 30atezolizumab 25Specimen Handling 25venetoclax 24Pemetrexed 24Magnetic Resonance Spectroscopy 24fludarabine 22Ipilimumab 22Docetaxel 22Bevacizumab 22Biopsy 21Radiotherapy 20Azacitidine 20Fluorouracil 19Dexamethasone 19Radiosurgery 18durvalumab 17Leucovorin 16olaparib 14Trastuzumab 14Cetuximab 14Capecitabine 14fludarabine phosphate 13Lenalidomide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Methods × 1 year × Clear all
NCT05452681 2026-05-07

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

University of Alabama at Birmingham

Phase NA Terminated
27 enrolled
Breast

Breast Neoplasms

NCT05243056 2026-05-06

A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment

University of Alabama at Birmingham

Phase NA Terminated
37 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT05477784 2026-01-21

EC-PC

University of Washington

Phase NA Terminated
174 enrolled
Tumor-Agnostic

Neoplasms

NCT05388851 2025-06-22

Education for Prevention of Melanoma in Hispanic Populations

Mayo Clinic

Phase 2 Terminated
145 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡